Dexamethasone Treatment Considerably Reduces the Levels of Some Inflammatory Cytokines, Lactate Dehydrogenase, and C-Reactive Protein in COVID-19 Pneumonia Patients With Pre-existing COPD

Dexamethasone Treatment Considerably Reduces the Levels of Some Inflammatory Cytokines, Lactate Dehydrogenase, and C-Reactive Protein in COVID-19 Pneumonia Patients With Pre-existing COPD

Background: Dexamethasone is the most widely used corticosteroid for treating COVID-19 pulmonary complications. The effects of dexamethasone on serum inflammatory factors, including C-reactive protein (CRP), lactate dehydrogenase (LDH), and cortisol, were evaluated in COVID-19 pneumonia patients wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Gholamreza Sepehri, Zeinab Fallah, Mitra Samareh Fekri, Behnam Dalfardi, Shahriar Dabiri, Hamid Daneshvar, Mohammad Javad Najafzadeh
Format: Article
Language:English
Published: Kerman University of Medical Sciences 2024-10-01
Series:Journal of Kerman University of Medical Sciences
Subjects:
covid-19
copd
dexamethasone
inflammatory cytokines
cortisol
c-reactive protein
lactate dehydrogenase
Online Access:https://jkmu.kmu.ac.ir/article_92258_c596ba0c22ae9cc1147fb7cdd650caf8.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jkmu.kmu.ac.ir/article_92258_c596ba0c22ae9cc1147fb7cdd650caf8.pdf

Similar Items